UNSPSC 51102903: Chloroquine/primaquine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AP101. This VA Drug Class (AP101) classifies this compound as belonging to the group ANTIMALARIALS.

UNSPSC 51102903 Chloroquine/primaquine, a Commodity code, shows little relevant recent activity. The three most recent state and local solicitations tagged under this code involve naloxone and drug deactivation systems procurement, therapeutic pharmacy initiatives for direct-to-manufacturer prescriptions, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing — none of which align with antimalarial pharmaceutical procurement. The mismatch between the code's nominal scope and the work actually being tagged suggests either tagging errors in the underlying procurement systems or that state and local governments are not currently soliciting chloroquine or primaquine through standard channels.

The one tangentially related opportunity is the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802), issued January 20, 2026, with proposals due March 26, 2026, which establishes framework contracts across state and local government facilities including Oregon. However, this solicitation focuses on high-volume generic and OTC categories distributed through three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health, and Morris & Dickson) and does not target specialized therapeutics like antimalarials. Absent evidence of direct chloroquine or primaquine solicitations from state health departments, corrections agencies, or other state and local end-users, this code does not represent an active procurement category worth pursuing at this time.